Ipswich Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-252
| Closed | -$265K | – | 197 |
|
|
2024
Q3 | $265K | Hold |
252
| – | – | 0.06% | 167 |
|
|
2024
Q2 | $265K | Buy |
252
+7
| +3% | +$7.36K | 0.06% | 167 |
|
|
2024
Q1 | $236K | Hold |
245
| – | – | 0.06% | 177 |
|
|
2023
Q4 | $215K | Hold |
245
| – | – | 0.05% | 181 |
|
|
2023
Q3 | $202K | Buy |
+245
| New | +$202K | 0.06% | 180 |
|
|
2023
Q2 | – | Sell |
-245
| Closed | -$201K | – | 195 |
|
|
2023
Q1 | $201K | Buy |
+245
| New | +$201K | 0.06% | 182 |
|
|
2019
Q1 | – | Sell |
-50
| Closed | -$19K | – | 334 |
|
|
2018
Q4 | $19K | Buy |
+50
| New | +$19K | 0.01% | 335 |
|
|
2016
Q2 | – | Sell |
-150
| Closed | -$56K | – | 283 |
|
|
2016
Q1 | $56K | Sell |
150
-400
| -73% | -$149K | 0.03% | 220 |
|
|
2015
Q4 | $299K | Hold |
550
| – | – | 0.13% | 106 |
|
|
2015
Q3 | $256K | Sell |
550
-50
| -8% | -$23.3K | 0.12% | 118 |
|
|
2015
Q2 | $306K | Sell |
600
-50
| -8% | -$25.5K | 0.14% | 102 |
|
|
2015
Q1 | $293K | Sell |
650
-50
| -7% | -$22.5K | 0.13% | 106 |
|
|
2014
Q4 | $287K | Hold |
700
| – | – | 0.12% | 103 |
|
|
2014
Q3 | $252K | Buy |
+700
| New | +$252K | 0.11% | 110 |
|
|
2014
Q2 | – | Sell |
-700
| Closed | -$210K | – | 146 |
|
|
2014
Q1 | $210K | Buy |
+700
| New | +$210K | 0.09% | 121 |
|
|
2013
Q4 | – | Sell |
-700
| Closed | -$219K | – | 148 |
|
|
2013
Q3 | $219K | Buy |
+700
| New | +$219K | 0.1% | 129 |
|